JP2022537339A5 - - Google Patents

Info

Publication number
JP2022537339A5
JP2022537339A5 JP2021575276A JP2021575276A JP2022537339A5 JP 2022537339 A5 JP2022537339 A5 JP 2022537339A5 JP 2021575276 A JP2021575276 A JP 2021575276A JP 2021575276 A JP2021575276 A JP 2021575276A JP 2022537339 A5 JP2022537339 A5 JP 2022537339A5
Authority
JP
Japan
Prior art keywords
antigens
autoantibodies
melanoma
autoantibody
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021575276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537339A (ja
Filing date
Publication date
Priority claimed from GBGB1908780.8A external-priority patent/GB201908780D0/en
Application filed filed Critical
Publication of JP2022537339A publication Critical patent/JP2022537339A/ja
Publication of JP2022537339A5 publication Critical patent/JP2022537339A5/ja
Pending legal-status Critical Current

Links

JP2021575276A 2019-06-19 2020-06-19 メラノーマバイオマーカー Pending JP2022537339A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1908780.8 2019-06-19
GBGB1908780.8A GB201908780D0 (en) 2019-06-19 2019-06-19 Melanoma biomarkers
PCT/EP2020/067245 WO2020254658A1 (en) 2019-06-19 2020-06-19 Melanoma biomarkers

Publications (2)

Publication Number Publication Date
JP2022537339A JP2022537339A (ja) 2022-08-25
JP2022537339A5 true JP2022537339A5 (enExample) 2023-09-12

Family

ID=67432302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575276A Pending JP2022537339A (ja) 2019-06-19 2020-06-19 メラノーマバイオマーカー

Country Status (6)

Country Link
US (1) US20220317125A1 (enExample)
EP (1) EP3987289A1 (enExample)
JP (1) JP2022537339A (enExample)
CN (1) CN115176159A (enExample)
GB (1) GB201908780D0 (enExample)
WO (1) WO2020254658A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024505333A (ja) 2020-12-21 2024-02-06 フリーノム ホールディングス,インク. 結腸細胞増殖障害の早期検出のためのマーカー
CN114910647A (zh) * 2022-05-07 2022-08-16 浙江大学 细丝蛋白-A-IgG抗体在制备检测血管内皮损伤试剂盒中的应用
KR102534243B1 (ko) * 2022-12-05 2023-05-31 넥스탭 주식회사 Eomes 단백질을 표적으로 하는 인터페론-γ 조절 물질의 확인방법 및 이 물질을 포함하는 의약
CN116159127B (zh) * 2023-01-17 2024-04-02 西安交通大学医学院第一附属医院 酸性核糖体蛋白p2在治疗焦虑症中的应用
CN118311257B (zh) * 2024-03-22 2025-03-28 安徽师范大学 子宫颈神经内分泌癌标志物在制备子宫颈神经内分泌癌诊断试剂中的应用
CN118604339A (zh) * 2024-05-09 2024-09-06 深圳市第二人民医院(深圳市转化医学研究院) Snrpa蛋白检测试剂在制备肝癌诊断试剂盒中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス.アー.エール.エル. 循環バイオマーカー
EP2806274A1 (en) * 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
EP3724661A1 (en) * 2017-12-12 2020-10-21 Oncimmune Germany GmbH Melanoma checkpoint inhibitor detection and treatment

Similar Documents

Publication Publication Date Title
JP6452718B2 (ja) 食物アレルギーを検出するためのペプチド、試薬及び方法
Rouquette et al. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods
JP5057402B2 (ja) 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
Hartmann et al. Protein microarrays for diagnostic assays
Bizzaro et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry
JP2019535015A5 (enExample)
US20190049439A1 (en) Kit for a Determination Method for Calprotectin and the Use of Calprotectin as a Predictive Marker for Cardiovascular Disease
CN105164535B (zh) 测定急性呼吸窘迫综合征(ards)相关生物标志物的方法、监测患者的ards的发展和治疗的方法
Homburger et al. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods
CN105723220A (zh) 能够测定广泛浓度范围的生物物质浓度的免疫层析条状传感器
JP6440719B2 (ja) 腎疾患のバイオマーカー
Tedesco et al. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach
Pividori et al. Electrochemical immunosensor for the diagnosis of celiac disease
CN115176159A (zh) 黑素瘤生物标志物
WO2009137129A2 (en) Rapid detection of anti-chromatin autoantibodies in human serum using a portable electrochemical biosensor
US7674632B1 (en) Method and composition for homogeneous multiplexed microparticle-based assay
CN101144810B (zh) 色谱快速试验的测定范围扩大
JP6366047B2 (ja) 抗体抗原反応評価方法
Harich et al. Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort
Fiegel et al. Autoantibodies to double-stranded DNA-Intermethod comparison between four commercial immunoassays and a research biosensor-based device
Olaussen et al. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA
CN116298234B (zh) 用于双相障碍区分和鉴别诊断的生物标记物
RU2193199C1 (ru) Тест-система для выявления опийной наркомании
JP3328058B2 (ja) 免疫診断薬の製造方法
JP4556605B2 (ja) 標的物質の測定方法および測定試薬